Richardson, G.E.; Al-Rajabi, R.; Uprety, D.; Hamid, A.; Williamson, S.K.; Baranda, J.; Mamdani, H.; Lee, Y.-L.; Nitika; Li, L.;
et al. A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors. Cancers 2023, 15, 2553.
https://doi.org/10.3390/cancers15092553
AMA Style
Richardson GE, Al-Rajabi R, Uprety D, Hamid A, Williamson SK, Baranda J, Mamdani H, Lee Y-L, Nitika, Li L,
et al. A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors. Cancers. 2023; 15(9):2553.
https://doi.org/10.3390/cancers15092553
Chicago/Turabian Style
Richardson, Gary Edward, Raed Al-Rajabi, Dipesh Uprety, Anis Hamid, Stephen K. Williamson, Joaquina Baranda, Hirva Mamdani, Ya-Li Lee, Nitika, Li Li,
and et al. 2023. "A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors" Cancers 15, no. 9: 2553.
https://doi.org/10.3390/cancers15092553
APA Style
Richardson, G. E., Al-Rajabi, R., Uprety, D., Hamid, A., Williamson, S. K., Baranda, J., Mamdani, H., Lee, Y.-L., Nitika, Li, L., Wang, X., & Dong, X.
(2023). A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors. Cancers, 15(9), 2553.
https://doi.org/10.3390/cancers15092553